Pamrevlumab for IPF, Dapagliflozin in Critical Illness, Payer Involvement in Evidence Generation, and more
- Author
- American Medical Association
- Published
- Tue 06 Aug 2024
- Episode Link
- https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.8289
Editor’s Summary by Mary McGrae McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the August 6, 2024, issue.
